Axonics, Inc. updated revenue guidance for the fiscal year 2022. The company expects Total company revenue of $238 million, an increase of 32% compared to fiscal year 2021. This compares to prior revenue guidance of $234 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.06 USD | +0.02% | -0.96% | +7.58% |
Apr. 04 | Boston Scientific, Axonics Receive FTC Second Request on Merger Deal | MT |
Apr. 04 | Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.58% | 3.42B | |
+8.85% | 125B | |
-10.82% | 10.51B | |
-5.04% | 8.65B | |
+21.71% | 4.77B | |
-0.46% | 3.03B | |
-13.27% | 1.97B | |
-12.45% | 1.95B | |
-30.28% | 1.62B | |
-3.10% | 1.21B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Axonics, Inc. Updates Revenue Guidance for the Fiscal Year 2022